Clinical Trials

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05861947 2024-01-31

JIVAN

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT06182735 2023-12-27

CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma

9 enrolled

Carcinoma, Renal Cell

NCT04399876 2023-12-14

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

35 enrolled

Prostatic Neoplasms

NCT05732948 2023-11-29

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT05580107 2023-11-07

MDPK67b in Patients With Prostate Cancer

15 enrolled

Prostatic Neoplasms

NCT04308330 2023-10-26

NYMC195

CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

NCT05259319 2023-10-17

IMMUNOs-SBRT

GenitourinaryHead & NeckThoracic

92 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT06065592 2023-10-06

CAT_PB

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT06062355 2023-10-02

Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer

9 enrolled

Prostatic Neoplasms

NCT06049030 2023-09-26

A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

190 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06034015 2023-09-13

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

48 enrolled

Urinary Bladder Neoplasms

NCT05420519 2023-08-18

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT05420545 2023-08-18

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

36 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05468190 2023-08-18

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

48 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05902247 2023-06-13

225AcPSMAI&T

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05607693 2023-05-15

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

52 enrolled

Castration-Resistant Prostate Cancer

NCT05856630 2023-05-12

Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg

Prostatic Neoplasms

NCT05843305 2023-05-06

A Study of BPI-452080 in Subjects With Solid Tumors

87 enrolled

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT04768868 2023-02-24

WEE1

BreastGastrointestinalGenitourinaryGynecologic

350 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05533203 2023-01-23

Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

NCT03634982 2022-09-01

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

133 enrolled

Urinary Bladder Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Noonan Syndrome, Ovarian Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Skin Neoplasms, Thoracic Neoplasms, Uterine Neoplasms, Neoplasms, Squamous Cell

NCT03934827 2022-08-11

MICROBIOME

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

120 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Uterine Neoplasms

NCT04108247 2022-07-07

A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

39 enrolled

Prostate Cancer Castration-resistant Prostate Cancer

NCT03780075 2022-05-12

Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer

50 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT04819399 2022-04-05

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05235607 2022-02-11

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

DermatologicGastrointestinalGenitourinary

60 enrolled

Urinary Bladder Neoplasms, Carcinoma, Melanoma, Colorectal Neoplasms

NCT05124106 2021-12-13

In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours

Urinary Bladder Neoplasms

NCT04853498 2021-11-24

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets

120 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT02497599 2021-09-29

Intraoperative Dual-modality Imaging in Renal Cell Carcinoma

Carcinoma, Renal Cell

NCT04773951 2021-08-24

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

DermatologicGenitourinary

156 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma

NCT03421236 2021-04-28

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

25 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT04783636 2021-03-17

To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers

40 enrolled

Prostatic Neoplasms

NCT04664725 2020-12-11

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

18 enrolled

Prostate Cancer Patients

NCT03086174 2020-09-30

Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma

DermatologicGenitourinary

Kidney Neoplasms, Melanoma

NCT04107142 2019-09-27

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

BreastGastrointestinalGenitourinaryHead & NeckSarcoma

10 enrolled

Nasopharyngeal Carcinoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT03583125 2019-09-11

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinary

140 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Cholangiocarcinoma

NCT02976402 2019-07-23

SHARP

Prostate Cancer Adenocarcinoma

NCT02950064 2019-01-14

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

BreastGastrointestinalGenitourinaryGynecologic

95 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT02058680 2018-09-10

PSA

48 enrolled

Prostatic Neoplasms

NCT03464032 2018-03-13

A Study of BCD-135 in Patients With Advanced Solid Tumors

DermatologicGenitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Melanoma

NCT03076372 2018-02-27

A Study Evaluating MM-310 in Patients With Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

34 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03403595 2018-01-18

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

NCT03098160 2017-10-30

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

DermatologicGastrointestinalGenitourinaryHead & Neck

69 enrolled

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03164837 2017-05-24

68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients

Prostatic Neoplasms

NCT03029533 2017-01-24

Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

44 enrolled

Prostatic Neoplasms

NCT02140996 2016-10-14

MUC-1